NFL Reveals That Players Wearing Guardian Caps Reduced Concussion Rates by More than 50%

A lot of football players often suffer concussions because their sports usually involve contact. Concussions are brain injuries caused by a blow to an individual’s head, which may or may not result in the loss of consciousness.

These injuries sometimes cause temporary cognitive symptoms and have no specific cure. Concussion symptoms include confusion, headaches, loss of memory, lack of coordination, nausea and vomiting, ringing in the ears, dizziness, excessive fatigue and sleepiness.

Data from a 2017 study found that 99% of tested NFL players, 91% of college football players and 88% of CFL players suffered from various stages of chronic traumatic encephalopathy. This is a progressive brain condition that develops as a result of repeated concussions.

The risk of developing this condition is heightened by not wearing a guardian cap, which is why the NFL mandated that Guardian Caps be worn during practice earlier this year. Recently released data shows that in comparison to the previous three-year average, concussions among players in the NFL who wore Guardian Cap equipment decreased by more than 50% this summer.

The approved resolution required that defensive linemen, offensive linemen, linebackers and tight ends wear Guardian Caps during practice between the beginning of training camp and the second preseason game. Historically, rates of concussion recorded during this period have been elevated. At the time of the resolution’s approval, 11 concussions had been recorded among the aforementioned position groups. Six of these concussions were caused by contact to the face mask, which isn’t protected by the Guardian Cap. The previous three-year average for players in those position groups in the same time period stood at 23.

The executive VP of communications, public affairs and policy of the NFL, Jeff Miller, stated that concussions among players in other positions remained unchanged. He added that the cap’s performance exceeded the NFL’s expectations, especially with regard to the number of concussions recorded.

Even after the mandate expired, roughly 200 players continued to wear Guardian Caps. Currently, no final decision about the use of these safety equipment in 2023 and beyond has been made. However, the NFL remains focused on working with the NFL Players Association to address feedback from coaches, players and equipment managers. This comes after some issues with fit and sizing were raised. Miller emphasized that the NFL planned to resolve these issues before the league was ready to make a commitment for next season, adding that league officials were optimistic that the equipment would improve the health and safety of the athletes.

Attention from companies such as Odyssey Health Inc. (OTC: ODYY) is also being directed toward finding better ways to treat concussion. A time may come when athletes no longer suffer the long-term debilitating effects of brain injuries incurred during their playing days.

NOTE TO INVESTORS: The latest news and updates relating to Odyssey Health Inc. (OTC: ODYY) are available in the company’s newsroom at https://ibn.fm/ODYY

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.